Europe Transient Protein Expression Market
The Europe Transient Protein Expression Market size was valued at US$ 247.78 Mn in 2023 and is projected to reach US$ 386.23 Mn by 2031, growing at a CAGR of 5.7% during 2023 - 2031.
Report Coverage
- Product Type: Instruments, Reagents, Expression Vectors, Competent Cells
- Application: Genomic Research, Gene Therapy, Bio production, Cancer Research, Drug Development
- End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations
US$ 247.78 Mn
Market size in 2023
US$ 386.23 Mn
Market Size by 2031
5.7%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Transient Protein Expression Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Transient Protein Expression Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Transient Protein Expression Market Regional Analysis
6.2 Europe Transient Protein Expression Market Revenue 2021-2031 (US$ Million)
6.3 Europe Transient Protein Expression Market Forecast Analysis
7. Europe Transient Protein Expression Market Analysis – by Product Type
7.1 Instruments
- 7.1.1 Overview
- 7.1.2 Instruments: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Reagents
- 7.2.1 Overview
- 7.2.2 Reagents: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Expression Vectors
- 7.3.1 Overview
- 7.3.2 Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Competent Cells
- 7.4.1 Overview
- 7.4.2 Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Transient Protein Expression Market Analysis – by Application
8.1 Genomic Research
- 8.1.1 Overview
- 8.1.2 Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Gene Therapy
- 8.2.1 Overview
- 8.2.2 Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Bio production
- 8.3.1 Overview
- 8.3.2 Bio production: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cancer Research
- 8.4.1 Overview
- 8.4.2 Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Development
- 8.5.1 Overview
- 8.5.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Transient Protein Expression Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biotechnology Companies: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Academic and Research Institutes: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Clinical Research Organizations
- 9.3.1 Overview
- 9.3.2 Clinical Research Organizations: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Transient Protein Expression Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Transient Protein Expression Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 UK: Europe Transient Protein Expression Market Breakdown, by Product Type
- 10.2.1.1.2 UK: Europe Transient Protein Expression Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Transient Protein Expression Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Germany: Europe Transient Protein Expression Market Breakdown, by Product Type
- 10.2.1.2.2 Germany: Europe Transient Protein Expression Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Transient Protein Expression Market Breakdown, by End User
- 10.2.1.3 France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 France: Europe Transient Protein Expression Market Breakdown, by Product Type
- 10.2.1.3.2 France: Europe Transient Protein Expression Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Transient Protein Expression Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Russia: Europe Transient Protein Expression Market Breakdown, by Product Type
- 10.2.1.4.2 Russia: Europe Transient Protein Expression Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Transient Protein Expression Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Italy: Europe Transient Protein Expression Market Breakdown, by Product Type
- 10.2.1.5.2 Italy: Europe Transient Protein Expression Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Transient Protein Expression Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by Product Type
- 10.2.1.6.2 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Merck KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN NV
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 GenScript Biotech Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Promega Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Takara Bio Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Agilent Technologies Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Mirus Bio LLC
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Bio-Rad Laboratories Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Lonza Group AG
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 MaxCyte Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
